π
|
Radiomics: the bridge between medical imaging and personalized medicine
20 auth.
P. Lambin,
R. Leijenaar,
T. Deist,
J. Peerlings,
E. D. Jong,
J. V. Timmeren,
S. Sanduleanu,
R. Larue,
A. Even,
A. Jochems,
...
Y. V. Wijk,
H. Woodruff,
J. V. Soest,
T. Lustberg,
E. Roelofs,
W. V. Elmpt,
A. Dekker,
F. Mottaghy,
J. Wildberger,
S. Walsh
|
11 |
2017 |
11 π
|
π
|
Decision support systems for personalized and participative radiation oncologyβ
39 auth.
P. Lambin,
J. Zindler,
B. Vanneste,
Lien Van De Voorde,
D. Eekers,
I. Compter,
Kranthi M Panth,
J. Peerlings,
R. Larue,
T. Deist,
A. Jochems,
T. Lustberg,
J. van Soest,
E. D. de Jong,
A. Even,
...
B. Reymen,
N. Rekers,
M. V. van Gisbergen,
E. Roelofs,
S. Carvalho,
R. Leijenaar,
C. Zegers,
M. Jacobs,
J. V. van Timmeren,
P. Brouwers,
J. A. Lal,
L. Dubois,
A. Yaromina,
E. V. Van Limbergen,
M. BerbΓ©e,
W. van Elmpt,
C. Oberije,
B. Ramaekers,
A. Dekker,
L. Boersma,
F. Hoebers,
K. Smits,
A. Berlanga,
S. Walsh
|
7 |
2017 |
7 π
|
π
|
Decision Support Systems in Oncology
16 auth.
S. Walsh,
E. D. de Jong,
J. E. van Timmeren,
A. Ibrahim,
I. Compter,
J. Peerlings,
S. Sanduleanu,
T. Refaee,
S. Keek,
R. Larue,
...
Y. van Wijk,
A. Even,
A. Jochems,
M. Barakat,
R. Leijenaar,
P. Lambin
|
6 |
2019 |
6 π
|
π
|
In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging
13 auth.
C. Zegers,
W. van Elmpt,
B. Reymen,
A. Even,
E. Troost,
M. OΜllers,
F. Hoebers,
R. Houben,
J. Eriksson,
A. Windhorst,
...
F. Mottaghy,
D. de Ruysscher,
P. Lambin
|
6 |
2014 |
6 π
|
π
|
Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion
11 auth.
W. van Elmpt,
C. Zegers,
B. Reymen,
A. Even,
A. Dingemans,
M. Oellers,
...
J. Wildberger,
F. Mottaghy,
M. Das,
E. Troost,
P. Lambin
|
6 |
2015 |
6 π
|
π
|
Modern clinical research: How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine
30 auth.
P. Lambin,
J. Zindler,
B. Vanneste,
L. Van De Voorde,
M. Jacobs,
D. Eekers,
J. Peerlings,
B. Reymen,
R. Larue,
T. Deist,
E. D. de Jong,
A. Even,
A. Berlanga,
E. Roelofs,
Qing Cheng,
...
S. Carvalho,
R. Leijenaar,
C. Zegers,
E. V. Van Limbergen,
M. BerbΓ©e,
W. van Elmpt,
C. Oberije,
R. Houben,
A. Dekker,
L. Boersma,
F. Verhaegen,
G. Bosmans,
F. Hoebers,
K. Smits,
S. Walsh
|
6 |
2015 |
6 π
|
π¦
|
PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes.
7 auth.
A. Even,
J. van der Stoep,
C. Zegers,
B. Reymen,
E. Troost,
P. Lambin,
...
W. van Elmpt
|
6 |
2015 |
6 π¦
|
π¦
|
Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach
15 auth.
A. Even,
O. Hamming-Vrieze,
W. van Elmpt,
V. Winnepenninckx,
J. Heukelom,
M. Tesselaar,
W. Vogel,
A. Hoeben,
C. Zegers,
D. Vugts,
...
G. V. van Dongen,
H. Bartelink,
F. Mottaghy,
F. Hoebers,
P. Lambin
|
5 |
2016 |
5 π¦
|
π
|
PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer.
19 auth.
J. V. van Loon,
A. Even,
H. Aerts,
M. OΜllers,
F. Hoebers,
W. van Elmpt,
L. Dubois,
A. Dingemans,
R. Lalisang,
Pascal Kempers,
...
B. Brans,
V. Winnepenninckx,
E. Speel,
E. Thunnissen,
K. Smits,
R. Boellaard,
D. Vugts,
D. de Ruysscher,
P. Lambin
|
5 |
2017 |
5 π
|
π¦
|
Clustering of multi-parametric functional imaging to identify high-risk subvolumes in non-small cell lung cancer.
9 auth.
A. Even,
B. Reymen,
M. L. La Fontaine,
M. Das,
F. Mottaghy,
J. Belderbos,
...
D. de Ruysscher,
P. Lambin,
W. van Elmpt
|
4 |
2017 |
4 π¦
|
π
|
Non-invasive imaging prediction of tumor hypoxia: a novel developed and externally validated CT and FDG-PET-based radiomic signatures.
30 auth.
S. Sanduleanu,
A. Jochems,
T. Upadhaya,
A. Even,
R. Leijenaar,
F. Dankers,
R. Klaassen,
H. Woodruff,
M. Hatt,
H. Kaanders,
O. Hamming-Vrieze,
H. V. van Laarhoven,
R. Subramiam,
S. Huang,
B. O'Sullivan,
...
S. Bratman,
L. Dubois,
R. Miclea,
Dario Di Perri,
X. Geets,
M. Crispin-Ortuzar,
A. Apte,
J. Deasy,
J. Oh,
N. Lee,
J. Humm,
H. SchΓΆder,
D. de Ruysscher,
F. Hoebers,
P. Lambin
|
4 |
2020 |
4 π
|
π
|
Defining the hypoxic target volume based on positron emission tomography for image guided radiotherapy β the influence of the choice of the reference region and conversion function
8 auth.
E. Lindblom,
A. Dasu,
J. Uhrdin,
A. Even,
W. van Elmpt,
P. Lambin,
...
P. WersΓ€ll,
I. Toma-Dasu
|
4 |
2017 |
4 π
|